Basic Stats
| CIK | 868368 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Rochester Medical Corporation
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| November 25, 2013 |
- ROCHESTER MEDICAL CORP 15-12G 11-25-2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 0-18933 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specifie |
|
| November 18, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 16) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorize |
|
| November 14, 2013 |
As filed with the Securities and Exchange Commission on November 14, 2013 Registration No. |
|
| November 14, 2013 |
AMENDED AND RESTATED ARTICLES OF INCORPORATION ROCHESTER MEDICAL CORPORATION EX-3.1 2 a13-242205ex3d1.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED ARTICLES OF INCORPORATION OF ROCHESTER MEDICAL CORPORATION FIRST: The name of the this corporation is Rochester Medical Corporation (the “Corporation”). SECOND: The name and address of the registered office of the Corporation in the State of Minnesota is: CT Corporation, 100 South 5th Street, Suite 1075, Minneapolis, MN 55402, At |
|
| November 14, 2013 |
8-K 1 a13-2422058k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number: 0—18933 Minnesota 41-1613227 |
|
| November 14, 2013 |
As filed with the Securities and Exchange Commission on November 14, 2013 Registration No. |
|
| November 14, 2013 |
As filed with the Securities and Exchange Commission on November 14, 2013 Registration No. |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Rochester Medical Corporation (Name of Issuer) Common Stock, no par value 771497104 (Title of class of securities) (CUSIP number) Peter M. Kreindler, Esq. Senior Vice President, General Counsel and Secretary C. R. Bard, Inc. 730 Central Avenue Murray Hi |
|
| November 14, 2013 |
As filed with the Securities and Exchange Commission on November 14, 2013 Registration No. |
|
| November 14, 2013 |
AMENDED AND RESTATED BY-LAWS ROCHESTER MEDICAL CORPORATION EX-3.2 3 a13-242205ex3d2.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF ROCHESTER MEDICAL CORPORATION Section 1. ARTICLES OF INCORPORATION AND BY-LAWS 1.1 These By-Laws are subject to the Articles of Incorporation of the corporation. In these By-Laws, references to the Articles of Incorporation and By-Laws mean the provisions of the Articles of Incorporation and the By-Laws as are from tim |
|
| November 14, 2013 |
As filed with the Securities and Exchange Commission on November 14, 2013 Registration No. |
|
| November 14, 2013 |
As filed with the Securities and Exchange Commission on November 14, 2013 Registration No. |
|
| November 13, 2013 |
Other Events, Submission of Matters to a Vote of Security Holders - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number: 0–18933 Minnesota 41-1613227 (State or other jurisdictio |
|
| November 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number: 0–18933 Minnesota 41-1613227 (State or other jurisdiction |
|
| November 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| October 18, 2013 |
DEFA14A 1 a13-213786defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (a |
|
| October 18, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number: 0–18933 Minnesota 41-1613227 (State or other jurisdiction |
|
| October 11, 2013 |
Exhibit 99.1 FOR IMMEDIATE RELEASE ROCHESTER MEDICAL TO HOLD SPECIAL MEETING OF SHAREHOLDERS NOVEMBER 13, 2013 TO APPROVE DEFINITIVE AGREEMENT TO BE ACQUIRED BY C. R. BARD STEWARTVILLE, Minn., October 10, 2013 — Rochester Medical Corporation (NASDAQ: ROCM), has established a record date and a special meeting date for the Company’s shareholders to consider and vote on the proposal to adopt the prev |
|
| October 11, 2013 |
EX-99.1 2 a13-213784ex99d1.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE ROCHESTER MEDICAL TO HOLD SPECIAL MEETING OF SHAREHOLDERS NOVEMBER 13, 2013 TO APPROVE DEFINITIVE AGREEMENT TO BE ACQUIRED BY C. R. BARD STEWARTVILLE, Minn., October 10, 2013 — Rochester Medical Corporation (NASDAQ: ROCM), has established a record date and a special meeting date for the Company’s shareholders to consider and |
|
| October 11, 2013 |
Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 11, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number: 0–18933 Minnesota 41-1613227 (State or other jurisdiction |
|
| October 11, 2013 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number: 0–18933 Minnesota 41-1613227 (State or other jurisdiction |
|
| October 10, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 15) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorize |
|
| October 1, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 14) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorize |
|
| September 30, 2013 |
Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 19, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 13) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorize |
|
| September 13, 2013 |
ROCM / Rochester Medical Corporation / BARD C R INC /NJ/ Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 ROCHESTER MEDICAL CORPORATION (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 771497104 (CUSIP Number) Jean F. Holloway, Esq. Vice President, General Counsel and Secretary C. R. Bard, Inc. 730 Central Avenue Murray Hill, New Jersey 07974 Telephon |
|
| September 9, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 12) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorize |
|
| September 6, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 11) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorize |
|
| September 5, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorize |
|
| September 4, 2013 |
Exhibit 3.2 SECOND AMENDED AND RESTATED BYLAWS OF ROCHESTER MEDICAL CORPORATION (As Amended Through September 3, 2013) ARTICLE I OFFICES, CORPORATE SEAL Section 1.01 Registered Office. The registered office of the corporation in Minnesota shall be that set forth in the articles of incorporation or in the most recent amendment of the articles of incorporation or resolution of the directors filed wi |
|
| September 4, 2013 |
EX-10.2 7 a13-201511ex10d2.htm EX-10.2 Exhibit 10.2 Execution Version NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of September 3, 2013 by and among C. R. Bard, Inc., a New Jersey corporation (the “Parent”), Rochester Medical Corporation, a Minnesota corporation (the “Company”), Starnorth Acquisition Corp., a Minnesota corporation and a wholly-owne |
|
| September 4, 2013 |
RESOLUTIONS OF THE BOARD OF DIRECTORS OF ROCHESTER MEDICAL CORPORATION Bylaw Amendment Exhibit 3.1 RESOLUTIONS OF THE BOARD OF DIRECTORS OF ROCHESTER MEDICAL CORPORATION Bylaw Amendment WHEREAS, Section 2.03 of the Amended and Restated Bylaws (“Bylaws”) of Rochester Medical Corporation (the “Company”) could be read to provide that any special meeting of the Company’s shareholders for the purpose of considering any action to directly or indirectly facilitate or affect a business comb |
|
| September 4, 2013 |
RESOLUTIONS OF THE BOARD OF DIRECTORS OF ROCHESTER MEDICAL CORPORATION Bylaw Amendment EX-3.1 4 a13-201511ex3d1.htm EX-3.1 Exhibit 3.1 RESOLUTIONS OF THE BOARD OF DIRECTORS OF ROCHESTER MEDICAL CORPORATION Bylaw Amendment WHEREAS, Section 2.03 of the Amended and Restated Bylaws (“Bylaws”) of Rochester Medical Corporation (the “Company”) could be read to provide that any special meeting of the Company’s shareholders for the purpose of considering any action to directly or indirectly |
|
| September 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number: 0–18933 Minnesota 41-1613227 (State or other jurisdictio |
|
| September 4, 2013 |
EX-10.1 6 a13-201511ex10d1.htm EX-10.1 Exhibit 10.1 Execution Version NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of September 3, 2013 by and among C. R. Bard, Inc., a New Jersey corporation (the “Parent”), Rochester Medical Corporation, a Minnesota corporation (the “Company”), Starnorth Acquisition Corp., a Minnesota corporation and a wholly-owne |
|
| September 4, 2013 |
EX-2.2 3 a13-201511ex2d2.htm EX-2.2 Exhibit 2.2 EXECUTION VERSION VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”) dated as of September 3, 2013, is entered into among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Rochester Medical Corporation, a Minnesota corporation (the “Company”), identified on Schedule A hereto (each, a “Shareh |
|
| September 4, 2013 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., STARNORTH ACQUISITION CORP. and ROCHESTER MEDICAL CORPORATION Dated as of September 3, 2013 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 Directors and Officers 2 1.6 Effect o |
|
| September 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| September 4, 2013 |
Exhibit 10.1 Execution Version NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of September 3, 2013 by and among C. R. Bard, Inc., a New Jersey corporation (the “Parent”), Rochester Medical Corporation, a Minnesota corporation (the “Company”), Starnorth Acquisition Corp., a Minnesota corporation and a wholly-owned subsidiary of Parent (“MergerSub”), a |
|
| September 4, 2013 |
Rochester Medical to be Acquired by C. R. Bard for Approximately $262 Million EX-99.1 8 a13-201511ex99d1.htm EX-99.1 Exhibit 99.1 For Release 6:00 A.M., C.S.T. Wednesday, September 4th, 2013 Rochester Medical to be Acquired by C. R. Bard for Approximately $262 Million Stewartville, MN September 4, 2013 Rochester Medical Corporation (NASDAQ: ROCM) today announced it has entered into a definitive merger agreement with C. R. Bard, Inc. (NYSE: BCR) at a price of $20 per share, |
|
| September 4, 2013 |
Exhibit 2.2 EXECUTION VERSION VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT (this “Agreement”) dated as of September 3, 2013, is entered into among C. R. Bard, Inc., a New Jersey corporation (“Parent”), and the shareholders of Rochester Medical Corporation, a Minnesota corporation (the “Company”), identified on Schedule A hereto (each, a “Shareholder” and, collectively, the “Share |
|
| September 4, 2013 |
Rochester Medical to be Acquired by C. R. Bard for Approximately $262 Million EX-99.1 8 a13-201511ex99d1.htm EX-99.1 Exhibit 99.1 For Release 6:00 A.M., C.S.T. Wednesday, September 4th, 2013 Rochester Medical to be Acquired by C. R. Bard for Approximately $262 Million Stewartville, MN September 4, 2013 Rochester Medical Corporation (NASDAQ: ROCM) today announced it has entered into a definitive merger agreement with C. R. Bard, Inc. (NYSE: BCR) at a price of $20 per share, |
|
| September 4, 2013 |
EX-2.1 2 a13-201511ex2d1.htm EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among C. R. BARD, INC., STARNORTH ACQUISITION CORP. and ROCHESTER MEDICAL CORPORATION Dated as of September 3, 2013 TABLE OF CONTENTS Page ARTICLE I MERGER; EFFECT OF THE MERGER ON CAPITAL STOCK; CLOSING 2 1.1 The Merger 2 1.2 Articles of Merger 2 1.3 Articles of Incorporation 2 1.4 Bylaws 2 1.5 D |
|
| September 4, 2013 |
Exhibit 10.2 Execution Version NON-COMPETITION AGREEMENT THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of September 3, 2013 by and among C. R. Bard, Inc., a New Jersey corporation (the “Parent”), Rochester Medical Corporation, a Minnesota corporation (the “Company”), Starnorth Acquisition Corp., a Minnesota corporation and a wholly-owned subsidiary of Parent (“MergerSub”), a |
|
| September 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 3, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Commission File Number: 0–18933 Minnesota 41-1613227 (State or other jurisdictio |
|
| September 4, 2013 |
EX-3.2 5 a13-201511ex3d2.htm EX-3.2 Exhibit 3.2 SECOND AMENDED AND RESTATED BYLAWS OF ROCHESTER MEDICAL CORPORATION (As Amended Through September 3, 2013) ARTICLE I OFFICES, CORPORATE SEAL Section 1.01 Registered Office. The registered office of the corporation in Minnesota shall be that set forth in the articles of incorporation or in the most recent amendment of the articles of incorporation or |
|
| August 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) July 31, 2013 (Date of Event which Requires Fling of this Statement) Check the appropriate box to designate the rule pursuant to which thi |
|
| August 9, 2013 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM to Commission File Number: 0- |
|
| August 1, 2013 |
Summer 2013 Rochester Medical Corporation Investor Presentation Exhibit 99.1 Summer 2013 Rochester Medical Corporation Investor Presentation Outline . Company Overview . Investment Considerations . Global Revenue Growth Trend . Sound Growth Strategy . Market Opportunity & Product Lines . Financial Summary & Outlook 2 Company Overview . Founded in 1988 . Develop, manufacture and market innovative disposable incontinence and bladder drainage products . Advanced |
|
| August 1, 2013 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Commis |
|
| July 30, 2013 |
Rochester Medical Reports Fiscal 2013 Third Quarter Results EX-99.1 2 a13-175761ex99d1.htm EX-99.1 Exhibit 99.1 For Release 3:00 p.m., C.S.T. Tuesday, July 30th, 2013 Rochester Medical Reports Fiscal 2013 Third Quarter Results Stewartville, MN July 30, 2013 Rochester Medical Corporation (NASDAQ:ROCM) today announced operating results for its third quarter ended June 30, 2013. The Company reported sales of $16,991,000 for the current quarter compared to $15 |
|
| July 30, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Commiss |
|
| April 25, 2013 |
Rochester Medical Reports Fiscal 2013 Second Quarter Results EX-99.1 2 a13-108831ex99d1.htm EX-99.1 Exhibit 99.1 For Release 3:00 p.m., C.S.T. Thursday, April 25, 2013 Rochester Medical Reports Fiscal 2013 Second Quarter Results Stewartville, MN April 25, 2013 Rochester Medical Corporation (NASDAQ:ROCM) today announced operating results for its second quarter ended March 31, 2013. The Company reported sales of $16,635,000 for the current quarter compared to |
|
| April 25, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a13-1088318k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdictio |
|
| April 15, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized |
|
| March 13, 2013 |
March 12, 2013 Via EDGAR Mr. Kevin L. Vaughn Accounting Branch Chief Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street NE Washington, D.C. 20549-5549 RE: Rochester Medical Corporation Form 10—K for the fiscal year ended September 30, 2012 Filed December 19, 2012 Form 10-Q for the Quarter Ended December 31, 2012 Filed February 11, 2013 File No. 0—18933 Dear Mr. Va |
|
| February 25, 2013 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized |
|
| February 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Comm |
|
| February 1, 2013 |
EXECUTIVE OFFICER SEVERANCE AGREEMENT EX-10.1 2 a13-42031ex10d1.htm EX-10.1 Exhibit 10.1 EXECUTIVE OFFICER SEVERANCE AGREEMENT This Executive Officer Severance Agreement (the “Agreement”) is made as of [ , 2013], between ROCHESTER MEDICAL CORPORATION, a Minnesota corporation (the “Company”), and {Name} (the “Executive”). Background Executive is employed by the Company at its headquarters in Stewartville, Minnesota. The purpose of this |
|
| January 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 8) Rochester Medical Corporation (Name of Issuer) Common Stock, without par value (Title of Class of Securities) 771497 10 1 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| January 29, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2013 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Comm |
|
| January 29, 2013 |
Rochester Medical Reports Fiscal 2013 First Quarter Results EX-99.1 2 a13-39211ex99d1.htm EX-99.1 Exhibit 99.1 For Release 3:00 p.m., C.S.T. Tuesday, January 29, 2013 Rochester Medical Reports Fiscal 2013 First Quarter Results Stewartville, MN January 29, 2013 Rochester Medical Corporation (NASDAQ:ROCM) today announced operating results for its first quarter ended December 31, 2012. The Company reported record sales of $17,252,000 for the current quarter c |
|
| December 28, 2012 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 28, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Com |
|
| December 28, 2012 |
Exhibit 99.1 FOR IMMEDIATE RELEASE December 28, 2012 Rochester Medical Director Benson E. Smith to Retire from the Company’s Board Stewartville, MN December 28, 2012 Rochester Medical Corporation (NASADQ: ROCM) today announced that board member Benson E. Smith has decided to retire from the Company’s Board of Directors when his current term expires on January 31, 2013. Mr. Smith is Chief Executive |
|
| December 18, 2012 |
Exhibit 10.1 Rochester Medical Corporation Fiscal 2013 Management Incentive Plan (adopted by the Compensation Committee of the Board of Directors on December 12, 2012) EXECUTIVE MANAGEMENT INCENTIVE PLAN (BONUS) Eligibility · All Executive Officers will be eligible to participate. · Recommended participation rates have been set by the President, and are based upon the respective position level and |
|
| December 18, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction (Commission file numbe |
|
| December 14, 2012 |
SEC FILE NUMBER: 0-18933 CUSIP NUMBER: 771497104 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 27, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Com |
|
| November 27, 2012 |
Winter 2012-2013 Rochester Medical Corporation Investor Presentation Exhibit 99.1 Winter 2012-2013 Rochester Medical Corporation Investor Presentation Outline Company Overview Investment Considerations Global Revenue Growth Trend Sound Growth Strategy Market Opportunity & Product Lines Financial Summary & Outlook 2 Company Overview Founded in 1988 Develop, manufacture and market innovative disposable incontinence and bladder drainage products Advanced technology co |
|
| November 13, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Com |
|
| November 13, 2012 |
Exhibit 99.1 For Release 3:00 p.m., C.S.T. Tuesday, November 13, 2012 Rochester Medical Reports Record Fourth Quarter and Fiscal Year Results Provides An Update to Fiscal 2013 Outlook Stewartville, MN November 13, 2012 Rochester Medical Corporation (NASDAQ:ROCM) today announced operating results for its fourth quarter and fiscal year ended September 30, 2012. The Company reported record sales and |
|
| November 6, 2012 |
Exhibit 99.1 For Immediate Release Tuesday, November 6th, 2012 Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business Significant Cost Savings Expected Stewartville, MN November 6th, 2012 Rochester Medical Corporation (NASDAQ:ROCM) today announced its decision to cease manufacturing and marketing its line of Foley Catheters, including its StrataSITM and StrataNFTM adv |
|
| November 6, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Comm |
|
| August 9, 2012 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized |
|
| July 26, 2012 |
Rochester Medical Reports Third Quarter Results EX-99.1 2 a12-170991ex99d1.htm EX-99.1 Exhibit 99.1 Rochester Medical Reports Third Quarter Results Stewartville, MN July 26, 2012 Rochester Medical Corporation (NASDAQ:ROCM) today announced operating results for its third quarter ended June 30, 2012. The Company reported sales of $15,252,000 for the current quarter compared to $14,281,000 for the third quarter of last year. It also reported net i |
|
| July 26, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 26, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Commiss |
|
| May 31, 2012 |
ROCM / Rochester Medical Corporation / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) Rochester Medical Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 771497104 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized |
|
| April 24, 2012 |
Rochester Medical Reports Second Quarter Results EX-99.1 Exhibit 99.1 Rochester Medical Reports Second Quarter Results Stewartville, MN April 24, 2012 Rochester Medical Corporation (NASDAQ:ROCM) today announced operating results for its second quarter ended March 31, 2012. The Company reported record sales of $15,259,000 for the current quarter compared to $12,853,000 for the second quarter of last year. It also reported net income of $603,000 o |
|
| April 24, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporation) (Commis |
|
| January 30, 2012 |
ROCHESTER MEDICAL CORPORATION 2010 STOCK INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT Form of 2010 Stock Incentive Plan Restricted Stock Award Agreement for directors Exhibit 10. |
|
| January 30, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporati |
|
| January 30, 2012 |
Schedule 13G Amendment No. 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 7) Rochester Medical Corporation (Name of Issuer) Common Stock, without par value (Title of Class of Securities) 771497 10 1 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the app |
|
| January 30, 2012 |
ROCHESTER MEDICAL CORPORATION 2010 STOCK INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT Form of 2010 Stock Incentive Plan Restricted Stock Award Agreement for employees Exhibit 10. |
|
| January 30, 2012 |
ROCHESTER MEDICAL CORPORATION 2010 STOCK INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT Form of 2010 Exhibit 10.3 ROCHESTER MEDICAL CORPORATION 2010 STOCK INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT This RESTRICTED STOCK UNIT AWARD AGREEMENT (the “Agreement”) is made this day of , , by and between Rochester Medical Corporation, a Minnesota corporation (the “Company”) and , an individual resident of , (“Employee”). 1. Award. The Company hereby grants to Employee an award of r |
|
| January 25, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 25, 2012 ROCHESTER MEDICAL CORPORATION (Exact name of registrant as specified in its charter) Minnesota 0-18933 41-1613227 (State or other jurisdiction of incorporati |
|
| January 25, 2012 |
Rochester Medical Reports Fiscal 2012 First Quarter Results Exhibit 99.1 Exhibit 99.1 Rochester Medical Reports Fiscal 2012 First Quarter Results Stewartville, MN January 25, 2012 Rochester Medical Corporation (NASDAQ:ROCM) today announced operating results for its first quarter ended December 31, 2011. The Company reported sales of $13,846,000 for the current quarter compared to $10,946,000 for the first quarter of last year. It also reported net loss of |
